Accelerate to discover

Back to filter

Related topics

ACCELA Educational webinar series: Unlocking Spatial Biology with RareCyte Orion Technology

RareCyte

Nov 16, 2022

Discover full slide, high-plex biomarker quantitation with the all-in-one spatial biology...

Practical aspects of an imaging study: live in vivo scanning

MOLECUBES

Nov 11, 2022

In this webinar, MOLECUBES will present a live in vivo demonstration, showing the entire workflow from animal...

All inside your incubator: xCELLigence eSight

Agilent technologies

Nov 3, 2022

Multiplex Live cell imaging and real-time biosensor measurement with xCELLigence eSight

Download the newest AVATAR data presented at CAR-TCR

Xcell Biosciences

Oct 21, 2022

Xcell Bio CSO, James Lim, presented new data showcasing improved potency of AVATAR-expanded CAR T cells and highlighted...

Nov 27, 2022

RareCyte Orion system advances Multi-modal digital pathology for colorectal cancer diagnosis

RareCyte

Oct 19, 2022

Precision medicine is critically dependent on better methods for diagnosing and staging disease and predicting drug...

Introducing MARS system : revolutionary solution for your workflow of cell separation and enrichment

Applied Cells

Oct 7, 2022

The MARS family of instruments provides a breakthrough solution to complete the workflow of cell separation and...

AMI HTX installation in CEMEX Iasi, Romania

Spectral Instruments Imaging

Sep 30, 2022

Presentation movie

Nov 27, 2022

Introducing RareCyte Orion, integrating Spatial Biology with Multiplex Imaging

RareCyte

Sep 13, 2022

Orion, the highly multiplexed fluorescent imaging system, empower investigators to unlock spatial context for key...

Show all topics (10)

Intelligent immune target screening

Feb 23, 2016

As drug discovery teams turn back to phenotypic screening in the hopes of improving lead identification, high-content imaging (HCI) is becoming the method of choice for secondary compound screens and even primary screens with smaller, directed libraries. But these systems are optimized for adherent cells, leaving researchers who are focused on suspension cells, such as immune cells, with either low-throughput methods like flow cytometry and microscopy, or low-content methods like plate readers. In addition, high-end HCI systems can be expensive, finicky, and complicated to use, with long per-plate data acquisition times.

The iQue Screener is filling this gap by enabling high-throughput high-content screening of suspension cells. Easily screen large libraries formatted in 96-, 384- or 1536-well plates, generating rich, multi-readout datasets in a fraction of the time that a high-end high-content imaging system takes. Get the data you need to prioritize compounds and move your discovery program into high gear with the iQue Screener.

Application
Product news

Related technologies: Conventional flow cytometry | HTP Screening

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey